Personalized medicine

E Faulkner, L Annemans, L Garrison, M Helfand, AP Holtorf, J Hornberger, D Hughes, et al. “Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group.” Value Health 15, 1162–1171 (2012).

Faulkner, Eric C, AP Holtorf, M Longacre, and Lieven Annemans. 2011. Value-Based Reimbursement For Personalized Medicine: Where Do We Stand? ‘Value in Health‘. Madrid, Spain, November.

Edward J. Moler, PhD , Louis P. Garrison, Jr, PhD,  Harald Rinde, MD, MBA, Janice Kolberg, PhD , Sean D. Sullivan, PhD. “The Value of Personalized, Predictive Risk-assessment Tools for the Prevention of Chronic Diseases”. JSM 2010 (Joint Statistical Meeting, Ontario, Jul-2010.